Benzimidazole amido derivatives as kinase inhibitors

US7956190B2 · kind B2 · utility

Assignee

• Hoffmann-La Roche Inc. · US

Inventors

• Guy Georges · Habach, DE
• Eike Hoffmann · Viernheim, DE
• Klaus Kaluza · Bad Heilbrunn, DE
• Matthias Koerner · Antdorf, DE
• Ulrike Reiff · Penzberg, DE
• Stefan Weigand · Wuppertal, DE

Key dates

• Filing date: Jun 23, 2008
• Grant date: Jun 7, 2011
• Expiry date: Jun 23, 2028

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D401/04
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Objects of the present invention are the compounds of formula (I) their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, medicaments containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer.